Skip to content

Effects of Local Insulin on Wound Angiogenesis

Effects of Local Insulin on Angiogenesis in Acute Wounds in Non-diabetic Patients

Status
UNKNOWN
Phases
Phase 3
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02396888
Enrollment
20
Registered
2015-03-24
Start date
2014-10-31
Completion date
2015-05-31
Last updated
2015-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Angiogenesis

Keywords

Blood vessel, Fibroplasia, Wound healing, Insulin

Brief summary

Randomized, split plot, double-blind, placebo controlled trial. Half of the wounds surface was applied daily with insulin and the other half with saline solution as placebo. Biopsy specimens of the two sides were obtained on days 0 and 14. Number of blood vessels will be evaluated as main outcome.

Detailed description

Randomized, split plot, double-blind, placebo controlled trial. Non-diabetic patients with full-thickness wounds will be treated in the following manner: in half of the surface insulin will be applied in a daily basis, on the other half, saline solution will be used as placebo. Biopsy specimens of both sides will be obtained on days 0 and 14. Number of blood vessels will be evaluated as main outcome.

Interventions

DRUGInsulin

Half of the wound surface was treated daily with 10 units of intermediate insulin.

DRUGPlacebo

Half of the wound surface was treated daily with 0.1 cc of normal saline.

Sponsors

Universidad Autonoma de San Luis Potosí
CollaboratorOTHER
Hospital Central Dr. Ignacio Morones Prieto
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Caregiver)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Nondiabetic patients with full-thickness acute wounds

Exclusion criteria

* Diabetic patients

Design outcomes

Primary

MeasureTime frameDescription
Number of blood vessels14 daysIn a biopsy taken at baseline, blood vessels will be counted

Secondary

MeasureTime frameDescription
Hypoglycaemia14 daysPresence of capillary blood glucose of \<60 mg/dl

Countries

Mexico

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026